“Complete Academic Physician” Dr. Karl Insogna Retires From Clinical Duties
During his childhood in Wolcott, Conn., Karl Insogna’s parents instilled in him a few life lessons. Insogna, MD, FACP, Ensign Professor of Medicine (Endocrinology); director, Yale Bone Center; and associate director, Yale Center for X-Linked Hypophosphatemia; was taught to strive to leave the world a better place than you found it, and to do something to help others.
Are Ozempic and Wegovy Safe? All About the Diabetes and Obesity Drugs
PEOPLE spoke with Ania Jastreboff M.D., PhD., an obesity medicine physician scientist at Yale University to better understand the drugs and correct common misconceptions about obesity By Sheila Cosgrove Baylis Published on January 24, 2023 02:28 PMSource: People
High liver fat associated with impaired glucose, type 2 diabetes in pediatric obesity
Children with obesity and a high level of liver fat content are more likely to have impaired glucose tolerance, prediabetes and type 2 diabetes compared with those with normal liver fat content, according to Sonia Caprio, MD.Source: Healio
Clinical Research Forum Chooses Carpenter's Work as One of the Year's Top Ten Research Achievements
The Clinical Research Forum has presented its 2019 Top Ten Clinical Research Achievement Awards, which include work by Thomas O. Carpenter, MD, professor of pediatrics (endocrinology) and of orthopaedics and rehabilitation, and clinical professor of nursing.
Gut bacteria differs in obese youth
Obese children and teens have different bacteria living in their digestive tracts than their leaner peers, according to a Yale-led study. The findings could help researchers develop strategies to target specific gut microbes with the goal of preventing or treating obesity in youth, said the researchers.
Welcome New Staff, Postdocs, Postgrads, and Clinical Fellows in the Section of Endocrinology and Metabolism (September 2023)
The Section of Endocrinology and Metabolism is pleased to welcome the following new staff, postdoctoral associates, clinical fellows, and postgraduate fellows and associates.
Introducing the Internal Medicine 2021-2022 Annual Report
In the new report, there are updates from our clinical programs, research endeavors, our work on diversity, equity, and inclusion, and educational programs. Our faculty members were honored for their educational excellence. Research initiatives at Yale received applause on the national and international stages. This book highlights all that we have accomplished together this past year…
3 Factors Keeping Americans From New Weight-Loss Drugs
The shifts in attitude about obesity can also be seen in the KFF survey, said Dr. Ania Jastreboff, an endocrinologist and obesity-medicine specialist at Yale University and a consultant for the makers of the new drugs. After decades of hearing that losing weight was just a matter of exerting willpower, most of the public is intensely interested in medical treatments.Source: The New York Times